dressing alginate superficial wound (Kaltostat 168212)
What to know about dressing alginate superficial wound — also sold as Kaltostat 168212, Comfeel SeaSorb Dressing 3705, Algisite M 66000521, Algisite M 66000519, Kaltostat 168210 and 3 more: uses, side effects, interactions, and safety considerations for people taking it or caring for someone who is.
dressing alginate superficial wound (brand names: Kaltostat 168212, Comfeel SeaSorb Dressing 3705, Algisite M 66000521, Algisite M 66000519, Kaltostat 168210 and 3 more) is classified as Minimal risk by AllMeds. Non-therapeutic wound dressing with no systemic absorption or pharmacological effects.
Key Takeaways
- Risk level: Minimal (0 points)
- PBS listed: Subsidised under the Australian Pharmaceutical Benefits Scheme
Scheduling and Classification
| Jurisdiction | Classification | Status |
|---|---|---|
| Australia (TGA) | Unscheduled | PBS listed |
Risk Profile
Non-therapeutic wound dressing with no systemic absorption or pharmacological effects.
How dressing alginate superficial wound is regulated
dressing alginate superficial wound is overseen by medicines regulators in each country. The rules below explain how it's scheduled, what oversight applies, and what to discuss with your doctor or pharmacist before starting, changing, or stopping this medication.
Australia TGA / PBS / State Schemes
Classified as Unscheduled under the Therapeutic Goods Administration (TGA).
Listed on the Pharmaceutical Benefits Scheme (PBS) for subsidised prescribing.
Check this medication against your full medication list
Run a full risk assessment including dressing alginate superficial wound interactions and compliance checks.
Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.
Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.